Early worsening heart failure in patients admitted with acute heart failure – a new outcome measure associated with long‐term prognosis?
暂无分享,去创建一个
C. O'connor | N. Uriel | K. Adams | Z. Vered | E. Kaluski | G. Cotter | B. Weatherley | O. Milo-Cotter | G. Michael Felker
[1] C. O'connor,et al. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. , 2008, Journal of cardiac failure.
[2] J. Cleland,et al. Clinical trials update from the American College of Cardiology 2008: Carisma, Trends, meta‐analysis of Cox‐2 studies, Hat, on‐Target, Hyvet, Accomplish, Momentum, Protect, Horizon‐hf and Reverse , 2008, European journal of heart failure.
[3] M. Gheorghiade,et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. , 2008, European heart journal.
[4] K. Furie,et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.
[5] C. O'connor,et al. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. , 2007, JAMA.
[6] J. Cleland,et al. Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC‐HF and KW‐3902 , 2006, European journal of heart failure.
[7] N. Freemantle,et al. Clinical trials update from the American Heart Association: REPAIR‐AMI, ASTAMI, JELIS, MEGA, REVIVE‐II, SURVIVE, and PROACTIVE , 2006, European journal of heart failure.
[8] C. O'connor,et al. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). , 2005, American heart journal.
[9] Dario Gregori,et al. Temporal trends in survival and hospitalizations in outpatients with chronic systolic heart failure in 1995 and 1999. , 2005, Journal of cardiac failure.
[10] Eliot Corday,et al. Overview of Acutely Decompensated Congestive Heart Failure (ADHF): A Report from the ADHERE Registry , 2005, Heart Failure Reviews.
[11] C. Richter,et al. The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure , 2004, European journal of heart failure.
[12] C. O'connor,et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. , 2004, American heart journal.
[13] M. Gheorghiade,et al. Hospitalization for worsening chronic heart failure. , 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.
[14] P. Austin,et al. Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. , 2004, The American journal of medicine.
[15] Peter C Austin,et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. , 2003, JAMA.
[16] B. Brendorp,et al. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. , 2003, European heart journal.
[17] P. Varadarajan,et al. Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients. , 2003, Journal of cardiac failure.
[18] N Freemantle,et al. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.
[19] D. DeMets,et al. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.
[20] James B. Young. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial , 2002 .
[21] M. Cuffe. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. , 2002, JAMA.
[22] M C Oz,et al. Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.
[23] A. Takeshita,et al. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. , 2001, The American journal of cardiology.
[24] F. Zannad,et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine. , 1999, Journal of the American College of Cardiology.